Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Activation of Checkpoint Kinase 2 by 3,3′-Diindolylmethane Is Required for Causing G2/M Cell Cycle Arrest in Human Ovarian Cancer Cells

Prabodh K. Kandala and Sanjay K. Srivastava
Molecular Pharmacology August 2010, 78 (2) 297-309; DOI: https://doi.org/10.1124/mol.110.063750
Prabodh K. Kandala
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay K. Srivastava
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 78 no. 2 297-309
DOI 
https://doi.org/10.1124/mol.110.063750
PubMed 
20444961

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 25, 2010
  • Accepted May 5, 2010
  • Published online July 14, 2010.

Article Versions

  • Earlier version (May 5, 2010 - 08:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Prabodh K. Kandala and
  2. Sanjay K. Srivastava
  1. Department of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, Texas
  1. Address correspondence to:
    Dr. Sanjay K. Srivastava, Department of Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106. E-mail: sanjay.srivastava{at}ttuhsc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2010 to November 2023

AbstractFullPdf
May 20101910243
Jun 20101020162
Jul 20102652178
Aug 20102391528
Sep 2010831716
Oct 2010671815
Nov 201041710
Dec 2010371112
Jan 201127119
Feb 20114135
Mar 2011462027
Apr 20111673
May 2011331523
Jun 2011271216
Jul 2011311123
Aug 2011351825
Sep 2011301015
Oct 2011352213
Nov 2011301131
Dec 2011262040
Jan 2012292044
Feb 2012412835
Mar 2012412133
Apr 2012252627
May 2012294222
Jun 2012195124
Jul 2012153553
Aug 2012312124
Sep 2012261211
Oct 2012182516
Nov 2012272811
Dec 201213168
Jan 2013491928
Feb 201321207
Mar 2013112617
Apr 201318167
May 2013122214
Jun 2013131316
Jul 2013969
Aug 20131686
Sep 201323814
Oct 2013101419
Nov 20131286
Dec 20131443
Jan 20141033
Feb 201420715
Mar 2014725
Apr 201413712
May 2014111912
Jun 20149211
Jul 2014121610
Aug 2014420
Sep 20146104
Oct 20141483
Nov 201414149
Dec 20141442
Jan 20151494
Feb 20154124
Mar 201518108
Apr 201513102
May 20155117
Jun 20151791
Jul 20151093
Aug 20151387
Sep 201511141
Oct 2015165
Nov 2015824
Dec 2015832
Jan 20162389
Feb 2016101412
Mar 201617710
Apr 20164413
May 20169716
Jun 20161465
Jul 20161544
Aug 201613149
Sep 2016593
Oct 20163106
Nov 20168112
Dec 2016098
Jan 20170143
Feb 20170159
Mar 201712116
Apr 201701319
May 20170148
Jun 201701413
Jul 201711015
Aug 201731383
Sep 201721810
Oct 201702213
Nov 20171239
Dec 20170156
Jan 20181239
Feb 20181157
Mar 201831413
Apr 201802012
May 201821212
Jun 20181179
Jul 2018068
Aug 2018164
Sep 2018096
Oct 20182149
Nov 2018292
Dec 20184301
Jan 20191507
Feb 20192312
Mar 20191115
Apr 20192003
May 20191412
Jun 2019926
Jul 20191928
Aug 20191104
Sep 20191801
Oct 20191623
Nov 20192210
Dec 20192812
Jan 20201511
Feb 20201600
Mar 20201300
Apr 2020900
May 20201100
Jun 20203101
Jul 20201101
Aug 2020311
Sep 20207111
Oct 20201005
Nov 20202006
Dec 20201201
Jan 20211311
Feb 20211515
Mar 20211311
Apr 20212110
May 2021422
Jun 2021810
Jul 2021812
Aug 2021426
Sep 20211553
Oct 20211112
Nov 20211512
Dec 20211213
Jan 20222420
Feb 20223413
Mar 2022910
Apr 20221003
May 20221011
Jun 20222922
Jul 20221837
Aug 20222813
Sep 2022511
Oct 2022736
Nov 20221514
Dec 20221510
Jan 20231012
Feb 20231000
Mar 20231322
Apr 2023503
May 2023810
Jun 2023622
Jul 20232714
Aug 20231937
Sep 2023610
Oct 20231010
Nov 20231016

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 78 (2)
Molecular Pharmacology
Vol. 78, Issue 2
1 Aug 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Activation of Checkpoint Kinase 2 by 3,3′-Diindolylmethane Is Required for Causing G2/M Cell Cycle Arrest in Human Ovarian Cancer Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Activation of Checkpoint Kinase 2 by 3,3′-Diindolylmethane Is Required for Causing G2/M Cell Cycle Arrest in Human Ovarian Cancer Cells

Prabodh K. Kandala and Sanjay K. Srivastava
Molecular Pharmacology August 1, 2010, 78 (2) 297-309; DOI: https://doi.org/10.1124/mol.110.063750

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Activation of Checkpoint Kinase 2 by 3,3′-Diindolylmethane Is Required for Causing G2/M Cell Cycle Arrest in Human Ovarian Cancer Cells

Prabodh K. Kandala and Sanjay K. Srivastava
Molecular Pharmacology August 1, 2010, 78 (2) 297-309; DOI: https://doi.org/10.1124/mol.110.063750
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial and Antileukemic Transportan 10 Conjugates
  • Pharmacological characterization of zebrafish H1 receptor
  • Bhave and Forman
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics